Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia is a research paper published in Nature Genetics (2021). On theSindex it has a DataRank of 0. It has been cited 113 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: T32CA124334
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01CA222579
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: R01CA230631
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK111430
Cancer Prevention and Research Institute of Texas
Grant: RP160157
Cancer Prevention and Research Institute of Texas
Grant: RP170086
Cancer Prevention and Research Institute of Texas
Grant: RR140025
Cancer Prevention and Research Institute of Texas
Grant: RP180504
Cancer Prevention and Research Institute of Texas
Grant: RP180826
Cancer Prevention and Research Institute of Texas
Grant: RP190417
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
Grant: R01GM115682
NIGMS NIH HHS
Grant: R15 GM131263
NCI NIH HHS
Grant: R01 CA248736
NIH HHS
Grant: R21 OD017965
National Institutes of Health
Grant: 1R01CA248736-01
ITIM-receptors for cancer treatment
National Institutes of Health
Grant: 5R01GM115682-08
Suppression of mobile elements by p53 genes
National Institutes of Health
Grant: 1R15GM131263-01
Developmental timing of LINE-1 retrotransposition in mouse models
National Institutes of Health
Grant: 1R21OD017965-01A1
Novel Transgenic Mouse Models for L1 Retrotransposons in Development and Disease
National Institutes of Health
Grant: 5R01CA222579-05
Tumor suppression, p53 and retrotransposons
National Institutes of Health
Grant: 5R01DK111430-03
Molecular Analysis of Transcriptional Enhancers in Hematopoiesis
National Institutes of Health
Grant: 5R01CA230631-05
Targeting Metabolic Liabilities of Leukemia-Initiating Cells
National Institutes of Health
Grant: 5T32CA124334-04
Cancer Biology Training Grant
FWCI
15.35
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals